Early localized Lyme disease is caused by Borrelia burgdorferi, transmitted by Ixodes ticks, and presents 3–30 days after a tick bite. Erythema migrans (EM) is the hallmark finding, present in 70–80% of infected patients. [1-3] Diagnosis of typical EM is clinical — serologic testing is not recommended and is often falsely negative at this stage (<40% sensitivity). [4-6] Treatment with appropriate oral antibiotics leads to rapid and complete recovery in most patients. [1-2]
The following figure illustrates the spectrum of EM presentations, including the more common uniformly erythematous pattern, vesicular changes, and disseminated lesions:
1. History
- Tick exposure: Recent outdoor activity in an endemic area (northeastern US, upper Midwest, northern California); ask about hiking, camping, yard work [4][8]
- Tick bite: Only ~25–30% of patients recall a bite; ask about finding or removing a tick and estimated attachment duration (≥36 hours increases transmission risk) [9]
- Rash onset and progression: Expanding erythematous lesion at the bite site, typically appearing 7–14 days post-bite; usually painless and non-pruritic, may feel warm [1-2][10]
- Constitutional symptoms: Present in ~65% of US patients — fatigue, malaise, arthralgias, myalgias, headache, fever, chills [6]
- Important negatives: Absence of purulent drainage, rapid onset (<24 hours suggests hypersensitivity reaction to bite, not EM), intense pruritus (more suggestive of allergic reaction)
2. Alarm Features
- Multiple EM lesions → indicates early disseminated disease, not Stage 1 [2]
- Facial droop or cranial nerve palsy → neuroborreliosis (10–15% of untreated patients) [3]
- Syncope, presyncope, dyspnea, chest pain → Lyme carditis with AV block (1–2%); can be fatal [2-3]
- Severe headache with neck stiffness → lymphocytic meningitis [11]
- High-grade fever persisting >1 day on antibiotics → consider coinfection with Anaplasma or Babesia [4]
- Joint swelling (especially knee) → early disseminated or late Lyme arthritis
3. Medications
First-line treatment (IDSA/AAN/ACR 2020 — strong recommendation): [9]
- Doxycycline 100 mg PO BID × 10 days (preferred; also covers Anaplasma)
- Amoxicillin 500 mg PO TID × 14 days
- Cefuroxime axetil 500 mg PO BID × 14 days
Second-line (only if unable to take doxycycline AND beta-lactams):
- Azithromycin5–10 days[2][9]
Pediatric dosing: [8]
- Doxycycline 4 mg/kg/day divided BID × 10–21 days
- Amoxicillin 50 mg/kg/day divided TID × 14–21 days
- Cefuroxime 30 mg/kg/day divided BID × 14–21 days
Contraindicated/ineffective: First-generation cephalosporins, fluoroquinolones, and metronidazole have no reliable activity against B. burgdorferi.
Pregnancy: Doxycycline is generally avoided; amoxicillin or cefuroxime are preferred. Discuss risks/benefits of prophylaxis with the patient. [6]
A European RCT demonstrated non-inferiority of 7 days vs. 14 days of doxycycline for solitary EM, though current US guidelines still recommend 10 days. [12]
The following table summarizes the AAFP's antibiotic recommendations:
4. Diet
- No specific dietary triggers or restrictions for early Lyme disease
- Encourage adequate hydration, especially if febrile
- Probiotics may be considered during antibiotic therapy to reduce GI side effects (particularly with doxycycline)
- Doxycycline should be taken with food/water and upright positioning to reduce esophageal irritation; avoid dairy products within 2 hours of dosing
5. Review of Systems
- Constitutional: Fever, chills, fatigue, malaise, night sweats
- MSK: Arthralgias, myalgias (migratory)
- Neuro: Headache, facial weakness, paresthesias, radicular pain
- Cardiac: Palpitations, lightheadedness, syncope, chest pain
- Derm: Additional skin lesions at sites distant from the bite
- Lymphatic: Regional lymphadenopathy near the bite site
6. Collateral History and Family History
- Travel/exposure history: Recent travel to endemic regions; occupational or recreational tick exposure
- Household contacts: Others with tick bites or similar rashes (shared exposure environment)
- Pet exposure: Dogs and outdoor pets can carry ticks into the home
- Prior Lyme disease: Reinfection is possible; prior antibodies complicate serologic interpretation [4]
- Family history is not a significant contributor (Lyme is not hereditary), though shared geographic exposure is relevant
7. Risk Factors
- Geographic: Northeastern US (Virginia to Maine), upper Midwest (WI, MN), northern California — 14 states account for 95% of US cases [4][8]
- Seasonal: Peak May–August (nymphal Ixodes scapularis activity)
- Outdoor activities: Hiking, gardening, camping in wooded/grassy areas
- Tick attachment duration ≥36 hours: Significantly increases transmission risk [9]
- Lack of tick prevention measures: No repellent use, no tick checks, no protective clothing
- Age: Bimodal distribution — children 5–15 and adults 45–65
8. Differential Diagnosis
- Cellulitis: Typically tender, warm, rapidly spreading; lacks the gradual expansion and central clearing of EM
- Southern tick-associated rash illness (STARI): EM-like rash from Lone Star tick (Amblyomma americanum); overlapping geography in southeastern US; empiric antibiotics recommended when indistinguishable from Lyme [4]
- Tinea corporis: Annular, scaly border with central clearing; KOH prep positive
- Nummular eczema: Coin-shaped, pruritic, scaly plaques [3]
- Granuloma annulare: Flesh-colored to erythematous annular plaques; non-expanding
- Fixed drug eruption: Recurrent at same site with medication exposure
- Insect bite hypersensitivity reaction: Appears within hours (not days), usually <5 cm, pruritic, resolves within 48 hours
- Contact dermatitis: Pruritic, vesicular, corresponds to exposure pattern
- Erythema multiforme: Target lesions with 3 concentric zones; often on palms/soles
9. Past Medical History
- Prior Lyme disease: Reinfection possible; persistent antibodies make serologic diagnosis of new episodes challenging [4]
- Immunocompromising conditions: May alter presentation or response to treatment; consider ID consultation
- Beta-lactam or doxycycline allergy: Dictates antibiotic choice (azithromycin as second-line) [9]
- Pregnancy/lactation: Affects antibiotic selection
- Splenectomy or asplenia: Increases risk of severe babesiosis if coinfected
10. Physical Exam
- Erythema migrans: Expanding erythematous macule/patch ≥5 cm at the tick bite site; may be homogeneous, have central clearing ("bull's-eye"), or show enhanced central erythema — the uniformly red pattern is actually more common than the classic target [3][7][10]
- Warm to touch but rarely pruritic or painful [2]
- Vesicular or necrotic center: Uncommon variant [7]
- Regional lymphadenopathy: Ipsilateral to the bite site [6]
- Vital signs: Low-grade fever possible; tachycardia or bradycardia should raise concern for carditis
- Neurologic exam: Assess cranial nerves (especially CN VII), strength, sensation
- Cardiac auscultation: Irregular rhythm may suggest conduction abnormality
- Joint exam: Assess for effusion, particularly large joints
11. Lab Studies
- Typical EM: No lab testing recommended — diagnosis is clinical. Serology is often falsely negative early (<40% sensitivity in first 2 weeks) [4-6][13]
- Atypical EM: Two-tiered serologic testing (EIA → immunoblot or modified two-tier EIA) on acute-phase serum; repeat convalescent serology in 2–3 weeks if initially negative [5-6][13]
- If coinfection suspected (persistent high fever on antibiotics): CBC with differential (leukopenia, thrombocytopenia → Anaplasma; hemolytic anemia → Babesia), peripheral smear, LDH, indirect bilirubin, Anaplasma/Babesia PCR [4]
- Routine labs (CBC, CMP) are generally normal in early localized Lyme; mild transaminase elevation or ESR elevation may occur [8]
12. Imaging
- Not indicated for early localized Lyme disease (Stage 1)
- Imaging becomes relevant only in disseminated disease:
- Echocardiography if carditis suspected
- MRI brain/spine if neuroborreliosis suspected
- Joint imaging if arthritis develops
13. Special Tests
- Tick identification: If the tick is available, identification of Ixodes species supports the diagnosis and guides prophylaxis decisions [9]
- Skin biopsy with PCR: Can detect B. burgdorferi DNA from the EM margin; higher sensitivity than serology in early disease but limited availability and not standardized [6]
- Point-of-care: No validated rapid test currently in routine clinical use for early Lyme
- Novel testing: A single-tier Hybrid Lyme ELISA has shown >90% sensitivity for EM in early studies, potentially transforming early diagnosis, though not yet widely available [14]
14. ECG
- Obtain ECG if: Palpitations, syncope/presyncope, dyspnea, chest pain, or bradycardia on exam
- Lyme carditis findings: Varying degrees of AV block (first-degree → complete heart block), which can fluctuate rapidly; PR prolongation is the earliest finding [2-3]
- Not routinely indicated for uncomplicated early localized EM without cardiac symptoms
- High-degree AV block (second-degree type II or third-degree) → emergent cardiology consultation and admission for temporary pacing and IV antibiotics
15. Assessment
- Early localized Lyme disease is a clinical diagnosis based on the characteristic expanding EM rash (≥5 cm) in the setting of plausible tick exposure in an endemic area [1][5][13]
- The classic "bull's-eye" pattern is present in a minority of cases; most EM lesions are uniformly erythematous or have enhanced central erythema [3][7][10]
- Constitutional symptoms (fatigue, arthralgias, myalgias, headache) accompany the rash in ~65% of US patients [6]
- Prognosis is excellent with appropriate antibiotic therapy — rapid and complete recovery is expected [1-2][6]
- Without treatment, ~60% of patients progress to disseminated disease (neurologic, cardiac, or rheumatologic manifestations) [2]
16. Treatment Plan
Initial management
- Start empiric oral antibiotics immediately upon clinical diagnosis of EM — do not delay for serologic results [4][9][13]
- Preferred: Doxycycline 100 mg PO BID × 10 days (also provides coverage for Anaplasma coinfection) [9]
- Alternatives: Amoxicillin 500 mg TID × 14 days or cefuroxime axetil 500 mg BID × 14 days [9]
Supportive care
- NSAIDs or acetaminophen for constitutional symptoms (fever, myalgias, arthralgias)
- Adequate hydration
Post-exposure prophylaxis (if presenting with tick bite, no rash yet): [9][13]
- Doxycycline 200 mg single dose
What NOT to do
- Do not prescribe prolonged antibiotic courses (>14 days for EM) — no benefit and increased adverse effects [9][15]
- Do not order serologic testing for typical EM — it delays treatment and is unreliable early [5-6]
17. Disposition
- Discharge home: The vast majority of Stage 1 Lyme disease is managed entirely as an outpatient [2][6]
- Admission criteria:
- Symptomatic Lyme carditis (especially second- or third-degree AV block)
- Meningitis or severe neurologic involvement
- Inability to tolerate oral medications
- Hemodynamic instability
- Observation: Consider for patients with first-degree AV block with PR >300 ms or symptoms of presyncope
- Specialist consultation triggers:
- Infectious disease: Atypical presentation, immunocompromised host, treatment failure, pregnancy
- Cardiology: Any conduction abnormality
- Neurology: Cranial nerve palsy, meningitis, radiculopathy
18. Follow Up / Return Precautions
Follow-up timing
- PCP follow-up in 2–4 weeks to confirm rash resolution and symptom improvement
- EM should begin resolving within days of starting antibiotics; complete resolution typically within 2–4 weeks [6]
Return precautions — advise patients to return immediately for:
- New or expanding rash(es) at sites distant from the original bite
- Facial droop or weakness
- Severe headache, neck stiffness, or photophobia
- Palpitations, chest pain, syncope, or lightheadedness
- Joint swelling (especially knee)
- Persistent high fever (>1 day) despite antibiotics → evaluate for coinfection [4]
- Numbness, tingling, or shooting pains in extremities
Patient counseling
- Complete the full antibiotic course
- Tick prevention education: DEET-based repellents, permethrin-treated clothing, daily tick checks, prompt tick removal [6]
- Reassure that early treatment is highly effective and prevents progression to disseminated disease [2][6]
- Some patients may experience lingering subjective symptoms (fatigue, arthralgias) that typically improve over weeks to months; prolonged antibiotics are not beneficial for these symptoms [1][15]
References
1. Lyme Borreliosis. — Strle F, Strle K, Marques A, et al. Nature Reviews. Disease Primers. 2026.
2. Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers Sixth Edition. — Nancy Shadick MD MPH, Nancy Maher MPH, Dennis Hoak MD United States Centers for Disease Control and Prevention (2022). 2022.
3. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. — Sanchez E, Vannier E, Wormser GP, Hu LT. The Journal of the American Medical Association. 2016.
4. Lyme Disease: Updated Recommendations From the IDSA, AAN, and ACR. — Williams AL, Bevan J, Arnold MJ. American Family Physician. 2021.
5. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
6. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2021.
7. Lyme Disease. — Shapiro ED. The New England Journal of Medicine. 2014.
8. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Management of Tick-Borne Illness in the United States. — Ho BM, Davis HE, Forrester JD, et al. Wilderness & Environmental Medicine. 2021.
9. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis & Rheumatology. 2021.
10. What Is Lyme Disease?. — Patel B, Malani PN. The Journal of the American Medical Association. 2025.
11. Lyme Disease Tests. — National Library of Medicine (MedlinePlus) 2022.
12. Treatment of Erythema Migrans With Doxycycline for 7 Days Versus 14 Days in Slovenia: A Randomised Open-Label Non-Inferiority Trial. — Stupica D, Collinet-Adler S, Blagus R, et al. The Lancet. Infectious Diseases. 2023.
13. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Neurology. 2021.
14. A Novel Single-Tier Serologic Test to Diagnose All Stages of Lyme Disease. — Levin AE, Wormser GP, Horn EJ, et al. Journal of Clinical Microbiology. 2025.
15. Lyme Borreliosis: Diagnosis and Management. — Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. BMJ. 2020.